China Eyes Lower Drug Prices, Some By As Much As 30%, From Probes
This article was originally published in PharmAsia News
Executive Summary
China expects its investigations of foreign drug makers to lower prices for Chinese drugs, in GlaxoSmithKline's case, as much as 30%.